Location History:
- Fukuyama, JP (2012 - 2014)
- Edogawa-ku, JP (2015)
Company Filing History:
2 out of 3 
1 out of 987 
1 out of 49 
Years Active: 2012-2015
Title: Ayako Iijima: Innovator in Cardiac Therapeutics and Nucleic Acid Transfection
Introduction
Ayako Iijima is a prominent inventor based in Fukuyama, Japan. She has made significant contributions to the fields of cardiac therapeutics and nucleic acid transfection. With a total of 3 patents, her work is recognized for its innovative approaches to medical challenges.
Latest Patents
Iijima's latest patents include a prophylactic and/or therapeutic agent for cardiac infarction. This invention relates to a novel preventive and therapeutic drug for myocardial infarction, providing a solution for myocardial ischemia-reperfusion injury. The drug contains a lipid membrane structure that retains adenosine. Another notable patent is her composition for nucleic acid transfection. This invention offers a nucleic-acid-transfecting composition that exhibits low cytotoxicity, facilitating effective nucleic acid transfection into cells and improving expression within those cells. The composition includes a di(Calkyl)dimethylammonium halide and a phospholipid.
Career Highlights
Throughout her career, Ayako Iijima has worked with notable organizations such as Hokkaido System Science Co., Ltd. and Osaka University. Her experience in these institutions has contributed to her expertise and innovative capabilities in her field.
Collaborations
Iijima has collaborated with esteemed colleagues, including Hiroshi Kikuchi and Kouichi Hashimoto. These partnerships have likely enhanced her research and development efforts.
Conclusion
Ayako Iijima stands out as a significant figure in the realm of medical innovation, particularly in cardiac therapeutics and nucleic acid transfection. Her contributions continue to impact the scientific community and pave the way for future advancements.